Le Roy obtained a BSc (Hons) in Biochemistry from Queen’s University, Belfast and a PhD in Nutritional Biochemistry at Ulster University (2002). After a period of post-doctoral research, he became Quality Assurance Officer for Ulster’s Biomedical Sciences Research Institute (BMSRI). Le Roy set up the BMSRI Core Facility Units to support academic and commercial research, and since 2012 he has worked with colleagues to bring over £17.5m of research and innovation funding into the University and NI. In 2015 he was appointed Commercial Manager at C-TRIC (Clinical Translational Research Innovation Centre) where he worked closely with the Western Health and Social Care Trust, Ulster University, Derry City & Strabane District Council, North West Regional College, lnvestNI and local companies, to develop economic growth and supply bio-businesses with support and advice. Le Roy returned to Ulster as BMSRI’s Business Development Manager, managing the Core Facility Units and an expert team of Scientific Assistants/Officers.
Le Roy joined the GreenLight Team in June 2018 as Director of Corporate Development, and is now Chief Operating Officer.
He was awarded a prestigious fellowship in 2010 by Arthritis Research UK to perform diagnostics research in the University of Colorado, Denver, USA. He holds a PhD from Queen’s University Belfast, awarded in 2001 for work on drugs to reduce spread of brain cancers.
In his role as Chief Scientific Officer he oversees the translation of lab based research, via rigorous clinical trials, to novel treatments for a wide range of chronic conditions. His personal research focus with GreenLight Medicines is to identify phytocannabinoids which reduce pain and inflammatory signalling most effectively, in collaboration with Ulster University.
Rory started as part of GreenLight’s first sales team, overseeing the launch of GL products into Irish pharmacies. He is now part of the management team and is focused on growing the GreenLight brand in Ireland & the UK as well as introducing it to new markets in Europe and beyond.